Related content

Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma

By Lamm Wolfgang   Vogl Ursula Maria   Bojic Marija   Zielinski Christoph   Klingler Christoph   Kramer Gero   Schmidinger Manuela  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 101-106

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis

By Miyake Hideaki   Harada Ken-ichi   Kusuda Yuji   Fujisawa Masato  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1054-1059

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients

By Kim Hye   Park Hyung   Kwon Woo   Lee Ji   Tanigawara Yusuke   Lim Sun   Kim Hyo   Shin Sang   Ahn Jung   Rha Sun  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 825-835

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

By Negrier S.   Jäger E.   Porta C.   McDermott D.   Moore M.   Bellmunt J.   Anderson S.   Cihon F.   Lewis J.   Escudier B.   Bukowski R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 899-906

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study

By            

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 935-939

Spandidos Publications

Access to resources Recommend Favorite